Company intelligence / Profile preview

BrightSpec

Charlottesville, Virginia, United Statesbrightspec.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

BrightSpec develops and commercializes advanced molecular analysis instrumentation based on patented Molecular Rotational Resonance (MRR) spectroscopy. Their technology enables ultra-high resolution identification and quantification of small molecules—including chiral compounds—directly from complex mixtures, with applications in pharmaceuticals, chemicals, consumer goods, food & beverage industries. The company’s isoMRR product line streamlines workflows for structure validation, impurity monitoring, process optimization, and more. BrightSpec also offers laboratory services through BrightSpec Labs.

Industry: Drug Discovery Services

Partnerships

Technology licensed from University of Virginia and Harvard University

Beyond the preview

Go deeper on BrightSpec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BrightSpec.

Explore the full profile